Mirtaz 30 Tablet is a prescription-only medication containing Mirtazapine 30mg, a tetracyclic antidepressant used to treat major depressive disorder, generalised anxiety disorder, and insomnia. It is available in tablet form for oral administration. The therapeutic benefits of Mirtaz 30 Tablet are attributed to its ability to selectively block alpha-1 adrenergic receptors, antagonize 5-HT2 and 5-HT3 receptors, and stimulate 5-HT1A receptors. This unique mechanism of action contributes to its efficacy in treating conditions characterized by depression, anxiety, and insomnia. Mirtaz 30 Tablet is contraindicated in patients with hypersensitivity to Mirtazapine, severe hepatic impairment, or those taking MAO inhibitors. The most common adverse reactions include drowsiness, dizziness, and changes in libido. Initiation of treatment should be done under close medical supervision, and patients should be monitored for signs of increased appetite and weight gain. Regular follow-up appointments and laboratory tests are necessary to ensure optimal therapeutic response and minimize the risk of adverse events.